DekaBank Deutsche Girozentrale - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$4,743,000
+21.1%
26,750
-15.7%
0.01%
+18.2%
Q2 2021$3,916,000
+24.2%
31,750
+33.7%
0.01%
+10.0%
Q1 2021$3,154,000
+5.8%
23,7500.0%0.01%
-9.1%
Q4 2020$2,980,000
-1.3%
23,750
-11.9%
0.01%
-15.4%
Q3 2020$3,018,000
-70.1%
26,950
-89.2%
0.01%
-79.4%
Q3 2019$10,087,000
-27.7%
249,484
-26.8%
0.06%
-10.0%
Q2 2019$13,949,000
-11.4%
340,884
+16.6%
0.07%
-25.5%
Q1 2019$15,742,000
+71.3%
292,230
+35.6%
0.09%
+54.1%
Q4 2018$9,188,000
-41.6%
215,530
-26.2%
0.06%
-34.4%
Q3 2018$15,742,000
+48.3%
292,230
-6.4%
0.09%
+34.8%
Q2 2018$10,613,000
-12.5%
312,330
+1.6%
0.07%
-16.9%
Q1 2018$12,133,000
+1743.9%
307,330
+1526.1%
0.08%
+1560.0%
Q4 2017$658,0000.0%18,9000.0%0.01%0.0%
Q3 2017$658,000
+12.9%
18,9000.0%0.01%0.0%
Q2 2017$583,000
+15.4%
18,9000.0%0.01%0.0%
Q1 2017$505,000
-4.0%
18,900
-7.4%
0.01%
-16.7%
Q4 2016$526,000
-23.5%
20,400
+7.9%
0.01%
-25.0%
Q3 2016$688,000
+4.1%
18,9000.0%0.01%0.0%
Q2 2016$661,000
+61.6%
18,900
+18.9%
0.01%
+60.0%
Q1 2016$409,000
-50.9%
15,900
-5.4%
0.01%
-50.0%
Q4 2015$833,000
+102.7%
16,800
+1.8%
0.01%
+100.0%
Q3 2015$411,000
-17.3%
16,500
+5.1%
0.01%
-16.7%
Q2 2015$497,000
-13.6%
15,700
+4.0%
0.01%
-14.3%
Q1 2015$575,00015,1000.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders